PLK1 as an oncology target: current status and future potential
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference74 articles.
1. Plk5, a polo box domain-only protein with specific roles in neuron differentiation and glioblastoma suppression;de Carcer;Mol. Cell. Biol.,2011
2. Progress in the discovery of polo-like kinase inhibitors;McInnes;Curr. Topics Med. Chem.,2005
3. Targeting polo-like kinase 1 for cancer therapy;Strebhardt;Nat. Rev. Cancer,2006
4. Targeting polo-like kinase in cancer therapy;Degenhardt;Clin. Cancer Res.,2010
5. Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy;Strebhardt;Nat. Rev. Drug Discov.,2010
Cited by 87 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Structural Basis for Variations in Polo-like Kinase 1 Conformation and Intracellular Stability Induced by ATP-Competitive and Novel Noncompetitive Abbapolin Inhibitors;ACS Chemical Biology;2023-07-11
2. In silico screening of inhibitors for PLK1 from natural sources using SwissDock software for colorectal carcinoma;INTERNATIONAL CONFERENCE ON SCIENCE, ENGINEERING, AND TECHNOLOGY 2022: Conference Proceedings;2023
3. Anti-cancer drug molecules targeting cancer cell cycle and proliferation;Control of Cell Cycle & Cell Proliferation;2023
4. Structure-activity and mechanistic studies of non-peptidic inhibitors of the PLK1 polo box domain identified through REPLACE;European Journal of Medicinal Chemistry;2022-01
5. Recent progress in agents targeting polo-like kinases: Promising therapeutic strategies;European Journal of Medicinal Chemistry;2021-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3